These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1773950)

  • 1. Increased intestinal permeability in ankylosing spondylitis--primary lesion or drug effect?
    Morris AJ; Howden CW; Robertson C; Duncan A; Torley H; Sturrock RD; Russell RI
    Gut; 1991 Dec; 32(12):1470-2. PubMed ID: 1773950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased intestinal permeability in patients with rheumatoid arthritis: a side-effect of oral nonsteroidal anti-inflammatory drug therapy?
    Jenkins RT; Rooney PJ; Jones DB; Bienenstock J; Goodacre RL
    Br J Rheumatol; 1987 Apr; 26(2):103-7. PubMed ID: 3103807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of intestinal permeability in ankylosing spondylarthritis with a test using Cr-EDTA].
    Wendling D; Bidet A; Guidet M
    Rev Rhum Mal Osteoartic; 1990 Jan; 57(1):29-32. PubMed ID: 2108485
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperpermeability of the small intestine mucosa after prolonged application of non-steroidal anti-inflammatory drugs in patients with rheumatic diseases].
    Lebedeva VV; Gmoshinskiĭ IV; Mazo VK; Murav'ev IuV
    Eksp Klin Gastroenterol; 2008; (2):16-21. PubMed ID: 19148987
    [No Abstract]   [Full Text] [Related]  

  • 5. Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man.
    Bjarnason I; Fehilly B; Smethurst P; Menzies IS; Levi AJ
    Gut; 1991 Mar; 32(3):275-7. PubMed ID: 1901563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal mucosal permeability in inflammatory rheumatic diseases. II. Role of disease.
    Mielants H; De Vos M; Goemaere S; Schelstraete K; Cuvelier C; Goethals K; Maertens M; Ackerman C; Veys EM
    J Rheumatol; 1991 Mar; 18(3):394-400. PubMed ID: 1906939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of endotoxin in inflammatory rheumatic diseases--the effect of nonsteroidal anti-inflammatory agents on intestinal permeability].
    Busch J; Hammer M; Brunkhorst R; Wagener P
    Z Rheumatol; 1988; 47(3):156-60. PubMed ID: 3213262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased intestinal permeability in ankylosing spondylitis.
    Mielants H; Veys EM; De Vos M; Cuvelier C
    Gut; 1992 Aug; 33(8):1150. PubMed ID: 1398245
    [No Abstract]   [Full Text] [Related]  

  • 9. Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives.
    Martínez-González O; Cantero-Hinojosa J; Paule-Sastre P; Gómez-Magán JC; Salvatierra-Ríos D
    Br J Rheumatol; 1994 Jul; 33(7):644-7. PubMed ID: 8019793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small bowel permeability--a variable effect of NSAIDS.
    Choi VM; Coates JE; Chooi J; Thomson AB; Russell AS
    Clin Invest Med; 1995 Oct; 18(5):357-61. PubMed ID: 8529318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bowel permeability and CD45RO expression on circulating CD20+ B cells in patients with ankylosing spondylitis and their relatives.
    Vaile JH; Meddings JB; Yacyshyn BR; Russell AS; Maksymowych WP
    J Rheumatol; 1999 Jan; 26(1):128-35. PubMed ID: 9918253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of non-steroidal anti-inflammatory drugs on the human small intestine.
    Bjarnason I; Zanelli G; Prouse P; Williams P; Gumpel MJ; Levi AJ
    Drugs; 1986; 32 Suppl 1():35-41. PubMed ID: 3780475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis.
    Smith MD; Gibson RA; Brooks PM
    J Rheumatol; 1985 Apr; 12(2):299-305. PubMed ID: 4032403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs.
    Bjarnason I; Williams P; So A; Zanelli GD; Levi AJ; Gumpel JM; Peters TJ; Ansell B
    Lancet; 1984 Nov; 2(8413):1171-4. PubMed ID: 6150232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal permeability in Behçet's syndrome.
    Fresko I; Hamuryudan V; Demir M; Hizli N; Sayman H; Melikoğlu M; Tunç R; Yurdakul S; Yazici H
    Ann Rheum Dis; 2001 Jan; 60(1):65-6. PubMed ID: 11114285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: Pathophysiology of the intestinal mucosa in inflammatory bowel disease and arthritis: similarities and dissimilarities in clinical findings.
    Orchard T; Jewell DP
    Aliment Pharmacol Ther; 1997 Dec; 11 Suppl 3():10-5; discussion 15-6. PubMed ID: 9467974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal mucosal permeability in inflammatory rheumatic diseases. I. Role of antiinflammatory drugs.
    Mielants H; Goemaere S; De Vos M; Schelstraete K; Goethals K; Maertens M; Ackerman C; Veys EM
    J Rheumatol; 1991 Mar; 18(3):389-93. PubMed ID: 1906938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of age and disease state in nonsteroidal antiinflammatory drug associated gastric bleeding.
    Llewellyn JG; Pritchard MH
    J Rheumatol; 1988 Apr; 15(4):691-4. PubMed ID: 3397979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal permeability and inflammation in patients on NSAIDs.
    Sigthorsson G; Tibble J; Hayllar J; Menzies I; Macpherson A; Moots R; Scott D; Gumpel MJ; Bjarnason I
    Gut; 1998 Oct; 43(4):506-11. PubMed ID: 9824578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-steroidal anti-inflammatory agents increase intestinal permeability].
    Auer IO; Habscheid W; Hiller S; Gerhards W; Eilles C
    Dtsch Med Wochenschr; 1987 Jun; 112(26):1032-7. PubMed ID: 3109868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.